tert-Butyl 2-(3-bromophenyl)acetate

Catalog No. :
ACOTAV183
CAS No. :
197792-52-2
Molecular Formula :
C12H15BrO2
Molecular Weight :
271.15

IUPAC Name:tert-butyl 2-(3-bromophenyl)acetate

tert-Butyl 2-(3-bromophenyl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$63.00Login to see priceIn stockInquiry
5g95%$185.00Login to see priceIn stockIn stock
10g95%$346.00Login to see priceIn stockIn stock
25g95%$680.00Login to see priceIn stockInquiry
100g95%$2378.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(3-bromophenyl)acetate
IUPAC Nametert-butyl 2-(3-bromophenyl)acetate
MDL No.MFCD19026476
Molecular FormulaC12H15BrO2
Molecular Weight271.15
SMILESO=C(OC(C)(C)C)CC1=CC=CC(Br)=C1
InChI KeyIUQYZZLJRJUKIH-UHFFFAOYSA-N
Synonymt-Butyl 2-(3-bromophenyl)acetate | (3-bromo-phenyl)-acetic acid tert-butyl ester | tert-butyl 2-(3-bromophenyl)acetate | AKOS013211639 | CS-0154838 | 3-Bromo-phenyl Acetic Acid Tert-butyl Ester | DS-19045 | EN300-1696604 | SCHEMBL2909498 | IUQYZZLJRJUKIH-
CAS No.197792-52-2
PubChem CID53936336

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACOTAV183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACWCKI172 route compound structure diagram
    ACWCKI1721878-67-7 In Stock
  4. Then
  5. ACOTAV183 route product structure diagram
    ACOTAV183197792-52-2 In Stock
Inquiry

2. ACOTAV183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWCKI172 route compound structure diagram
    ACWCKI1721878-67-7 In Stock
  2. Then
  3. ACOTAV183 route product structure diagram
    ACOTAV183197792-52-2 In Stock
Inquiry

Comments (0)